Cargando…
Multiple N-of-1 trials to investigate hypoxia therapy in Parkinson’s disease: study rationale and protocol
BACKGROUND: Parkinson’s disease (PD) is a neurodegenerative disease, for which no disease-modifying therapies exist. Preclinical and clinical evidence suggest that hypoxia-based therapy might have short- and long-term benefits in PD. We present the contours of the first study to assess the safety, f...
Autores principales: | Janssen Daalen, Jules M., Meinders, Marjan J., Giardina, Federica, Roes, Kit C. B., Stunnenberg, Bas C., Mathur, Soania, Ainslie, Philip N., Thijssen, Dick H. J., Bloem, Bastiaan R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9281145/ https://www.ncbi.nlm.nih.gov/pubmed/35836147 http://dx.doi.org/10.1186/s12883-022-02770-7 |
Ejemplares similares
-
How Vacations Affect Parkinson's Disease
por: Janssen Daalen, Jules M., et al.
Publicado: (2022) -
Reply to: Hypoxia treatment of Parkinson’s disease may disrupt the circadian system
por: Janssen Daalen, Jules M., et al.
Publicado: (2023) -
Including People with Parkinson’s Disease in Clinical Study Design and Execution: A Call to Action
por: Meinders, Marjan J., et al.
Publicado: (2022) -
The Impact of the COVID-19 Pandemic on Psychological Distress, Physical Activity, and Symptom Severity in Parkinson’s Disease
por: van der Heide, Anouk, et al.
Publicado: (2020) -
The state of telemedicine for persons with Parkinson's disease
por: van den Bergh, Robin, et al.
Publicado: (2021)